Life science pharmaceutical and drug development.
Cofactor Genomics uses RNA to diagnose disease. Their team of past Human Genome Project Scientists have created RNA based tests that are enabling drug companies to develop new drugs. Their tests will help physicians make personalized medicine a reality. They are providing valuable and unique diagnostics and disease monitoring for the 95% of diseases that can not be diagnosed by DNA. Cofactor s molecular detection technology allows us to detect specific RNAs 100X more sensitively than current methods and the result is they are detecting key molecules indicating disease. This molecular technology paired with Cofactor s Machine Learning based software is paving the way for new diagnostics that achieve the signal to noise separation necessary to make RNA based diagnostics a reality. They currently have the largest database of RNA profiles.
|Human health & social work||Other Legal Structure||Operating||11 - 50 employees|
Funding and Financing Rounds
- Social Policies and Performance
Impact Reports & Metrics
188 King Street
San Francisco, California 94107
United States of America